• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » J&J Innovation adds J-Labs incubator at Texas Medical Center

J&J Innovation adds J-Labs incubator at Texas Medical Center

October 24, 2014
CenterWatch Staff

Johnson & Johnson Innovation plans to expand J-Labs (formerly Janssen Labs) to include a new incubator located within Texas Medical Center's new Innovation Institute. The 30,000-square-foot J-Labs facility will accommodate up to 50 life science startups.

"As one of the top global biotechnology clusters, and home to the Texas Medical Center, the largest medical center in the world, Houston is a flourishing life science hub in which we see great potential for an incubator to enable the talented scientists in the region to take their innovation to the next level," said Melinda Richter, head of J-Labs, part of J&J Innovation. "The continued demand for our J-Labs model fueled our decision to expand with J-Labs @TMC, which furthers our goal of helping entrepreneurs advance science with the potential to become transformational solutions for patients."

J&J Innovation seeks to find the best science and technology, no matter where it is located, to solve the greatest unmet medical and healthcare needs of our time. J-Labs @TMC will link regional entrepreneurs with the full breadth of J&J Innovation, including opportunities to discuss funding, access third-party services, attend educational events and meet with R&D experts from J&J medical device and diagnostic technology, consumer healthcare product and Janssen pharmaceutical teams. J-Labs @TMC also will follow the same no-strings attached approach currently in operation at the California and Boston J-Labs facilities. 

The University of Texas is part of the Texas Medical Center. Texas Medical Center is a life science accelerator and one of the core components of the Texas Medical Center's Innovation Institute, which offers entrepreneurs a full spectrum of support, including curriculum about entrepreneurship, a network of advisors and mentors as well as access to strategic and venture investors.

The J-Labs network currently hosts 70 life science companies across its three active facilities located in San Diego, San Francisco (J-Labs @QB3) and Boston (J-Labs @LabCentral). J-Labs @South San Francisco will open in early 2015 and will accommodate up to 50 companies in the Bay Area. Applications currently are being accepted from biotech, pharmaceutical, medical device, diagnostics, consumer and digital health companies, across all J-Labs sites, including the Houston incubator.

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Revamp-360x240.png

    Califf Calls for Major Evidence Generation Revamp, Experts’ Opinions Differ

  • AskTheExpertsGreen-360x240.png

    Ask the Experts: Managing Investigational Products

  • SurveywBlueBackground-360x240.png

    Survey Outlines Site Challenges, Successes on Diversity

  • PatientCentricity-360x240.png

    Site Spotlight: DM Clinical Shows Patient Centricity Doesn’t Have to Break the Bank

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing